OR WAIT null SECS
Contract service providers must step up their game to stay competitive in increasingly complex bio/pharma market.
The need for preclinical testing expertise is growing as molecular complexity increases.
A look at the newest innovations offers a deeper understanding of affinity ligands and their role in the future of downstream processing.
January 09, 2017
UK-based Orchard Therapeutics and PharmaCell ally to support clinical trials and commercialization of Orchard’s ex-vivo gene therapies.
Catalent announces a development agreement with JOT to evaluate softgel options for a resveratrol drug candidate.
January 02, 2017
Robust venture capital investment gives CDMOs and CROs a positive outlook for 2017.
Healthcare policies, R&D investments, and drug approvals will test bio/pharma.
December 21, 2016
Pharma Tech introduced a new high-speed bottling line to its facility in Union, MO.
AGC adds second biopharma contract manufacturer with acquisition of CMC Biologics.
Novasep’s three facilities located in France and Germany are free of Form 483.
The company has manufactured double-digit number of batches on the new filling line, for use in early-stage clinical trials.
December 14, 2016
BMS changes its US geographic footprint with R&D investments and closures.
December 08, 2016
At the American Society of Hematology Annual Meeting, Novartis and Kite Pharma both released results from early-phase clinical trials with CAR-T therapies.